163 related articles for article (PubMed ID: 18089492)
1. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens.
Deng H; Shi J; Wilkerson M; Meschter S; Dupree W; Lin F
Am J Clin Pathol; 2008 Jan; 129(1):81-8. PubMed ID: 18089492
[TBL] [Abstract][Full Text] [Related]
2. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
[TBL] [Abstract][Full Text] [Related]
3. Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimens.
Lin F; Staerkel G
Cancer; 2003 Feb; 99(1):44-50. PubMed ID: 12589645
[TBL] [Abstract][Full Text] [Related]
4. Cytomorphology and B72.3 labeling of benign and malignant ductal epithelium in pancreatic lesions compared to gastrointestinal epithelium.
Nawgiri RS; Nagle JA; Wilbur DC; Pitman MB
Diagn Cytopathol; 2007 May; 35(5):300-5. PubMed ID: 17427224
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
[TBL] [Abstract][Full Text] [Related]
6. S100P and XIAP expression in pancreatic ductal adenocarcinoma: potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology.
Kosarac O; Takei H; Zhai QJ; Schwartz MR; Mody DR
Acta Cytol; 2011; 55(2):142-8. PubMed ID: 21325798
[TBL] [Abstract][Full Text] [Related]
7. Cytologic features of pancreatic intraepithelial neoplasia and pancreatitis: potential pitfalls in the diagnosis of pancreatic ductal carcinoma.
Jarboe EA; Layfield LJ
Diagn Cytopathol; 2011 Aug; 39(8):575-81. PubMed ID: 20730891
[TBL] [Abstract][Full Text] [Related]
8. Fine-needle aspiration cytology of intraductal papillary mucinous tumors of the pancreas.
Solé M; Iglesias C; Fernández-Esparrach G; Colomo L; Pellisé M; Ginés A
Cancer; 2005 Oct; 105(5):298-303. PubMed ID: 16015637
[TBL] [Abstract][Full Text] [Related]
9. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct.
Awadallah NS; Shroyer KR; Langer DA; Torkko KC; Chen YK; Bentz JS; Papkoff J; Liu W; Nash SR; Shah RJ
Pancreas; 2008 Mar; 36(2):200-6. PubMed ID: 18376314
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
Hosoda W; Takagi T; Mizuno N; Shimizu Y; Sano T; Yamao K; Yatabe Y
Pathol Int; 2010 May; 60(5):358-64. PubMed ID: 20518885
[TBL] [Abstract][Full Text] [Related]
11. Cystic pancreatic endocrine tumor: a variant commonly confused with cystic adenocarcinoma.
Deshpande V; Lauwers GY
Cancer; 2007 Feb; 111(1):47-53. PubMed ID: 17173321
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
13. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E
Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612
[TBL] [Abstract][Full Text] [Related]
14. Cytologic diagnosis of pancreatic endocrine tumors by endoscopic ultrasound-guided fine-needle aspiration: a review.
Chang F; Chandra A; Culora G; Mahadeva U; Meenan J; Herbert A
Diagn Cytopathol; 2006 Sep; 34(9):649-58. PubMed ID: 16900463
[TBL] [Abstract][Full Text] [Related]
15. Fine-needle aspiration of cystic pancreatic mucinous tumor: oncotic cell as an aiding diagnostic feature in paucicellular specimens.
Xiao GQ
Diagn Cytopathol; 2009 Feb; 37(2):111-6. PubMed ID: 19021219
[TBL] [Abstract][Full Text] [Related]
16. The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors.
Ali S; Cohen C; Little JV; Sequeira JH; Mosunjac MB; Siddiqui MT
Diagn Cytopathol; 2007 Oct; 35(10):644-8. PubMed ID: 17854080
[TBL] [Abstract][Full Text] [Related]
17. Telecytology of fine-needle aspiration biopsies of the pancreas: a study of well-differentiated adenocarcinoma and chronic pancreatitis with atypical epithelial repair changes.
Marchevsky AM; Nelson V; Martin SE; Greaves TS; Raza AS; Zeineh J; Cobb CJ
Diagn Cytopathol; 2003 Mar; 28(3):147-52. PubMed ID: 12619097
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis.
Lin F; Shi J; Liu H; Hull ME; Dupree W; Prichard JW; Brown RE; Zhang J; Wang HL; Schuerch C
Am J Surg Pathol; 2008 Jan; 32(1):78-91. PubMed ID: 18162774
[TBL] [Abstract][Full Text] [Related]
19. The role of S100P and IMP3 in the cytologic diagnosis of pancreatic adenocarcinoma.
Ezzat NE; Tahoun NS; Ismail YM
J Egypt Natl Canc Inst; 2016 Dec; 28(4):229-234. PubMed ID: 27839709
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma.
Sweeney J; Rao R; Margolskee E; Goyal A; Heymann JJ; Siddiqui MT
J Am Soc Cytopathol; 2018; 7(6):318-323. PubMed ID: 31043302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
